Is Testoluten FDA approved?
No. This profile records Testoluten as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE TESTOSTERONE RESTORER
A-17 Peptide; Testicular Bioregulator
Testoluten is a testis-derived bioregulator peptide that supports testosterone production and sperm health. It works by stimulating gene expression in Leydig and Sertoli cells, promoting steroidogenesis and spermatogenesis. It's used for andropause, subfertility, recovery after steroid use, and age-related testicular decline.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Testoluten as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 20 mg daily (oral or subcutaneous).
Schedule: daily. Cycle: 4 weeks on, 12 weeks off (repeat every 3-6 months). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Upregulates StAR, CYP11A1, and 17β-HSD
Increases Leydig cell response to LH
Activates genes for sperm development (DAZL, SYCP3)
Enhances DNA repair and antioxidant gene expression
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.